Cerebra

What Cerebra does

Cerebra is a privately held Canadian health technology company headquartered in Winnipeg, Manitoba, that develops diagnostic technology systems for sleep assessments and the diagnosis of sleep disorders. Founded in 2015 and operating with a team of 11 to 50 employees, the company operates in the sleep-medicine diagnostics segment of digital health, building tools that assist clinicians in evaluating conditions such as sleep-disordered breathing, insomnia, and related pathologies. The product surface, deployment model (software, hardware-integrated, or hybrid), and target end users (patients, sleep clinics, hospitals, payers) are not disclosed in the available data; the public website (cerebra.health) returned only a loader/verification page when scraped, leaving these dimensions undocumented.\n\nThe company was founded by Magdy Younes, who serves as Scientific Founder — an academic-led origin that points to a research-grounded technology foundation in sleep physiology and diagnostics. The current leadership bench pairs this scientific authority with commercial execution: Nicholas Kosciolek as Chief Executive Officer and Patrick Crampton as Chief Commercial Officer, with John Proven serving as a Director. The presence of a dedicated Scientific Founder role, combined with a separately staffed CCO function, suggests an organization structured to translate proprietary clinical-science IP into a commercial sleep-diagnostics product rather than repackaging a horizontal technology for the sleep vertical.\n\nBusiness model specifics — pricing model, go-to-market channels, customer segments, and revenue mechanics — are not disclosed in the input. No funding rounds, M&A activity, partnerships, named customers, certifications, regulatory clearances, or revenue figures are reported. As a result, the company should be assessed as a small, narrowly focused, science-led diagnostics venture with a leadership team that signals both domain depth and commercialization intent, but with limited observable operating evidence at this snapshot.

Name

Cerebra

Website

https://cerebra.health

Company type

Private

Founded year

2015

Headcount range

11–50 employees

Short description

Cerebra is a Canadian health technology company founded in 2015 and headquartered in Winnipeg that develops diagnostic technology systems for sleep assessments and sleep-disorder diagnosis, operating with a small team under science-led and commercially-focused leadership.

Ownership category

akta.pro rank

Product category

Sleep Diagnostics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

akta.pro secondary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Sleep diagnostics
• Sleep disorder assessment
• Polysomnography systems
• Sleep medicine technology
• Diagnostic medical devices

Headquarters

HQ city

Winnipeg

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Core offering

Cerebra develops a diagnostic technology system for sleep assessments and sleep disorders diagnosis. The offering is intended for healthcare providers and clinical settings that need specialized tools to evaluate patients for sleep-related conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Technology System for Sleep Assessments Diagnostic technology system for sleep assessments and sleep disorders diagnosis, designed for healthcare providers, hospitals, and sleep clinics that need to evaluate patients for sleep-related conditions.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Compumedics: Australia-based manufacturer of clinical sleep diagnostics systems (PSG, EEG). Comparable to Cerebra in target market (sleep labs, clinics) and product category (diagnostic devices).
• Itamar Medical (ZOLL Itamar): WatchPAT and EndoPAT maker specializing in home sleep apnea diagnostics and vascular/autonomic testing. Comparable to Cerebra as a focused sleep-diagnostic technology competitor targeting clinicians and patients.
• Nox Medical: Icelandic medtech focused on polysomnography and home sleep testing hardware/software (Noxturnal). Most directly comparable peer to Cerebra as a specialized sleep diagnostic technology company.

Broad incumbents

• Koninklijke Philips (Philips Respironics): Large incumbent with a sleep & respiratory portfolio including home sleep testing devices (Alice NightOne, etc.) and PAP therapy. Comparable to Cerebra as an established competitor offering diagnostic and therapeutic sleep solutions.
• ResMed: Global leader in sleep-disordered breathing diagnostics and PAP therapy. Compares to Cerebra as a broad incumbent that overlaps significantly in sleep assessment, monitoring, and disorder management workflows.

Emerging players

• Withings: Consumer health hardware maker whose Sleep Analyzer offers an under-mattress sleep diagnostic. Comparable to Cerebra as a sleep-tracking device peer, though focused on consumer/retail channels.
• Empatica / Dreem: Consumer/clinical-grade sleep headband and wearable EEG diagnostic company. Comparable to Cerebra in sleep-monitoring hardware with neurology-grade signal capture.
• EarlySense: Contact-free bedside sleep and vital-sign monitoring for clinical and consumer markets. Comparable to Cerebra as a sleep-monitoring sensor company targeting both clinical and home settings.
• Cleveland Medical Devices / BioSerenity: Wearable EEG/sleep monitoring specialists (SleepTrack, Dreem-related technologies). Comparable to Cerebra in the EEG/neuro-based sleep diagnostics niche.
• Oura: Smart ring maker with sleep staging, readiness, and disorder-oriented features. Comparable to Cerebra in sleep-tracking consumer hardware with growing diagnostic ambitions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/cerebraofficial
• Facebookfacebook.com/cerebraofficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerebra